Leading oncologists and nutritionists pinpoint areas to catalyze nutrition-based cancer prevention

An international collaborative led by Ludwig Cancer Research and Cancer Research UK has identified key areas that are central to uncovering the complex relationship between nutrition and cancer. Advancing research on these core areas using a holistic, cross-disciplinary approach could catalyze progress urgently needed to prevent cancer and improve public health globally. Their main observations and conclusions are reported in a Forum article published online today in BMC Medicine.

"While data clearly show that obesity is a major risk factor for cancer, we still have a lot to learn about how diet, physical activity and other metabolic factors impact cancer development," said Bob Strausberg, deputy scientific director of the Ludwig Institute for Cancer Research. "In bringing together the most prominent experts in the field across institutions, disciplines and continents, we have worked to identify these research gaps and clarify the role of nutrition in cancer prevention."

Insights from the Forum article published today emerged from discussions during the inaugural international Cancer Prevention and Nutrition Conference held in London on December 3-4, 2018. The full list of the Cancer Research UK - Ludwig Cancer Research Nutrition and Cancer Prevention Collaborative Group is included in the manuscript here. The article includes several sections addressing main areas of concern as outlined by experts in each field who attended the conference.

Traditionally, there have been several methodological challenges with studying the impact of nutrition on cancer risk, development and treatment. Environmental exposures in early life--including diet--can influence cancer risk in the future. However, the impact of these factors has been difficult to track from childhood to adulthood. In addition, our understanding of the fundamental biologic mechanisms behind these long-term effects is limited.

"The complexity of the metabolic factors modulated by diet and physical activity may be a contributing factor for the lack of support for several prominent food and cancer hypotheses in large prospective studies," wrote section leads Walter Willett, professor of epidemiology and nutrition at the Harvard T.H. Chan School of Public Health, and Elio Riboli, chair in cancer epidemiology and prevention at Imperial College London.

The current nutrition and cancer evidence-base is largely observational and prone to confounding, and long-term diet is difficult to assess," added section leads Richard Martin, professor of clinical epidemiology at University of Bristol, and Edward Giovannucci, professor of nutrition and epidemiology at the Harvard T.H. Chan School of Public Health.

New analytical approaches and global networks are helping researchers to move from observational associations to causal links. Recent advances in omics technologies, combined with the creation of large research groups and population biobanks, have made high-dimensional molecular datasets from human samples more accessible. These tools are a valuable resource to advance our understanding of the causal underpinnings of cancer.

"With improved mechanisms to share data, enhanced collaboration across continents and cross-pollination increasing among traditional siloes--the links between nutrition and cancer prevention research are potentially more understandable and actionable," wrote Fiona Reddington, head of population, prevention and behavioral research funding at Cancer Research UK.

To best leverage these recent advances in the fields of nutrition and oncology, scientists urgently seek institutional support and funding for cancer prevention and nutrition research. "Resources are reluctantly applied to prevention, let alone early life factors that are decades removed from cancer occurrence," added Karin Michels, professor of epidemiology at University of California and Robert Waterland, professor of pediatrics-nutrition at Baylor College of Medicine. "We hope our pressing call to action will be heard."

Translating research on nutrition and diet into cancer prevention recommendations and policies that successfully change people's eating habits is equally important, according to the authors. Working with governments and healthcare professionals to limit the proliferation of unhealthy food options will continue to be critical.

"Research to inform the development of policies and interventions to improve the food environment and prioritize cancer and other noncommunicable disease prevention requires interdisciplinary collaborations," wrote Linda Bauld, professor of public health at the University of Edinburgh and Cancer Research UK/BUPA chair in cancer prevention, and Hilary Powers, emeritus professor of nutritional biochemistry at the University of Sheffield. "Researchers need skills not only in identifying appropriate context specific methods and analysis but also in knowledge translation and in engaging policy makers and the public."

The Cancer Research UK - Ludwig Cancer Research Nutrition and Cancer Prevention Collaborative Group.
Current opportunities to catalyze research in nutrition and cancer prevention - an interdisciplinary perspective.
BMC Medicinevolume 17, Article number: 148, doi: https://doi.org/10.1186/s12916-019-1383-9.

Most Popular Now

Roche's COVID-19 antibody test receives FDA Emerge…

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) (1) for its new Elecsys® Ant...

Pfizer and BioNTech dose first participants in the…

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced that the first participants have been dosed in the U.S. in the Phase 1/2 clinical trial for the BNT162 va...

Johnson & Johnson announces collaboration to e…

Johnson & Johnson (the Company) (NYSE: JNJ) announced a collaboration between the Janssen Pharmaceutical Companies of Johnson & Johnson and Emergent BioSolutions, Inc. to...

Researchers urge clinical trial of blood pressure …

Researchers in the Ludwig Center at the Johns Hopkins Kimmel Cancer Center report they have identified a drug treatment that could - if given early enough - potentially r...

Early indicators of vaccine efficacy

Ludwig-Maximilians-Universität (LMU) in Munich researchers have shown that a specific class of immune cells in the blood induced by vaccination is an earlier indicator of...

Official COVID-19 deaths underestimate the full im…

According to a study by Charité - Universitätsmedizin Berlin, the northern Italian city of Nembro recorded more deaths during March 2020 than between January and December...

Arthritis drug may improve respiratory function in…

A small study in Greece found that the clinically approved anti-inflammatory drug anakinra, used to treat rheumatoid arthritis, improved respiratory function in patients ...

Local climate unlikely to drive the early COVID-19…

Local variations in climate are not likely to dominate the first wave of the COVID-19 pandemic, according to a Princeton University study published May 18 in the journal ...

Frankfurt researchers discover potential targets f…

A team of biochemists and virologists at Goethe University and the Frankfurt University Hospital were able to observe how human cells change upon infection with SARS-CoV-...

AstraZeneca advances response to global COVID-19 c…

AstraZeneca is advancing its ongoing response to address the unprecedented challenges of COVID-19, collaborating with a number of countries and multilateral organisations...

Antibody neutralizes SARS and COVID-19 coronavirus…

An antibody first identified in a blood sample from a patient who recovered from Severe Acute Respiratory Syndrome in 2003 inhibits related coronaviruses, including the c...

Vitamin D linked to low virus death rate

A new study has found an association between low average levels of vitamin D and high numbers of COVID-19 cases and mortality rates across 20 European countries. The r...